Prognostic significance of the bcl2 apoptotic family of proteins in primary and recurrent cervical cancer
1998

Prognostic Significance of bcl2 Proteins in Cervical Cancer

Sample size: 74 publication Evidence: moderate

Author Information

Author(s): RAF Crawford, C Caldwell, RK lies, D Lowe, JH Shepherd, T Chard

Primary Institution: St. Bartholomew's Hospital, London, UK

Hypothesis

The study aims to determine the prognostic significance of bcl-2, mcl-1, bax, and p53 expression in primary and recurrent cervical cancer.

Conclusion

Positive bcl-2 staining is associated with better survival in primary cervical cancer, while p53 positivity indicates a worse outcome.

Supporting Evidence

  • bcl-2 positive patients had a 4-year survival of 84% compared to 53% for bcl-2 negative patients.
  • p53 positive patients had a 4-year survival of 38% compared to 78% for p53 negative patients.
  • mcl-1 and bax were not useful as prognostic indicators in primary disease.

Takeaway

If a patient has a lot of bcl-2 protein in their cervical cancer, they are more likely to live longer, but if they have a lot of p53, it might mean they won't do as well.

Methodology

Immunohistochemistry was used to analyze the expression of bcl-2, mcl-1, bax, and p53 in tissue samples from patients.

Limitations

The recurrent disease group was heterogeneous, which may have affected the prognostic value of the markers.

Participant Demographics

The median age of the primary group was 43 years and the median age of the recurrent group was 45 years.

Statistical Information

P-Value

0.03 for bcl-2, 0.02 for p53

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication